Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

  1. Spanjaart, A.M.
  2. Ljungman, P.
  3. de La Camara, R.
  4. Tridello, G.
  5. Ortiz-Maldonado, V.
  6. Urbano-Ispizua, A.
  7. Barba, P.
  8. Kwon, M.
  9. Caballero, D.
  10. Sesques, P.
  11. Bachy, E.
  12. Di Blasi, R.
  13. Thieblemont, C.
  14. Calkoen, F.
  15. Mutsaers, P.
  16. Maertens, J.
  17. Giannoni, L.
  18. Nicholson, E.
  19. Collin, M.
  20. Vaz, C.P.
  21. Metafuni, E.
  22. Martinez-Lopez, J.
  23. Dignan, F.L.
  24. Ribera, J.-M.
  25. Nagler, A.
  26. Folber, F.
  27. Sanderson, R.
  28. Bloor, A.
  29. Ciceri, F.
  30. Knelange, N.
  31. Ayuk, F.
  32. Kroger, N.
  33. Kersten, M.J.
  34. Mielke, S.
  35. Mostra tots els autors/es +
Revista:
Leukemia

ISSN: 1476-5551,  0887-6924

Any de publicació: 2021

Volum: 35

Número: 12

Pàgines: 3585-3588

Tipus: Article

DOI: 10.1038/S41375-021-01466-0 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus